|
Alnylam Scientist Awarded Two Industry Honors (Business Wire via Yahoo! Finance)
CAMBRIDGE, Mass.----Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today that Dr. Rachel Meyers, Director of Research at Alnylam, has been recognized with two industry honors.
(Feb 28, 2007)
Nanogen Awarded Patents for Biomarkers Associated with Diabetes, Alzheimers Disease (Business Wire via Yahoo! Finance)
SAN DIEGO----Nanogen, Inc. , developer of advanced diagnostic products, announced today that it has been issued four patents by the U.S. Patent and Trademark Office for inventions related to diabetes and Alzheimers disease biomarkers.
(Feb 28, 2007)
Researchers Review New Technologies For Detecting Biological Threats (Science Daily)
In an effort to detect biological threats quickly and accurately, a number of new detection technologies have been developed.
(Feb 28, 2007)
Uniform language for describing genes of pathogenic and beneficial microbes (EurekAlert!)
Blacksburg, Va., February 28, 2007 – An international group of scientists has announced a major expansion of a lingua franca used to describe the activities of genes in living organisms.
(Feb 28, 2007)
BioReference Laboratories Announces New Horizon Blue Cross Blue Shield of New Jersey Ancillary Services Arrangement (Business Wire via Yahoo! Finance)
ELMWOOD PARK, N.J.----BioReference Laboratories, Inc. announced today that it has reached an accord with Horizon Blue Cross Blue Shield of New Jersey to enable it to remain in the Horizon BCBSNJ PPO network.
(Feb 28, 2007)
Rhode Island Biotechnology Company Receives $ 368K Federal Grant to Reengineer Botulinum Toxin Using ... (Business Wire via Yahoo! Finance)
PROVIDENCE, R.I.----EpiVax, Inc, a leader in genome-derived vaccines, announced today that it has received a grant to reengineer botulinum toxin, a protein that is used for cosmetic purposes and which is also used as a revolutionary therapeutic for movement disorders categorized as "dystonias" such as Parkinson's Disease and Cerebral Palsy.
(Feb 28, 2007)
Language created for describing genes (UPI)
A U.S.-led international group of scientists has expanded a lingua franca used to describe the activities of genes in living organisms. The expansion is ...
(Feb 28, 2007)
Language created for describing genes (EARTHtimes.org)
A U.S.-led international group of scientists has expanded a lingua franca used to describe the activities of genes in living organisms.
(Feb 28, 2007)
OncoGenex Technologies Postpones IPO (AP via Yahoo! Finance)
Biotechnology company OncoGenex Technologies Inc. postponed its initial public offering because of market conditions, analysts said Wednesday.
(Feb 28, 2007)
Nanogen Awarded Patents for Biomarkers Associated With Diabetes, Alzheimers Disease (RedNova)
Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today that it has been issued four patents by the U.S. Patent and Trademark Office for inventions related to diabetes and Alzheimers disease biomarkers.
(Feb 28, 2007)
Applied Biosystems and Celera to Webcast Investor Meetings (Business Wire via Yahoo! Finance)
FOSTER CITY, Calif. & ALAMEDA, Calif.----Applied Biosystems Group and Celera Group , Applera Corporation businesses, will webcast meetings with investors to be held at Celera's offices in Alameda, California on March 7, 2007.
(Feb 28, 2007)
Schering-Plough Announces Executive Changes in Research (PR Newswire via Yahoo! Finance)
Schering-Plough Corporation today announced the appointment of Ismail Kola, Ph.D., as senior vice president, Discovery Research, in Schering-Plough Research Institute , and as the company's Chief Scientific Officer.
(Feb 28, 2007)
Integrated Genomics Files Suit to Defend Intellectual Property (Business Wire via Yahoo! Finance)
CHICAGO----Integrated Genomics , a leading microbial genomics company, today announced that it has filed a lawsuit against two former employees for breach of their employment contracts with IG, including breach of their non-competition and non-solicitation obligations.
(Feb 28, 2007)
|
